Application DetailsWestern Blotting (WB) and Immunohistochemistry (IHC). A concentration of 0.5 µg/mL is recommended for WB. Human Cytoskeletal 19 (precursor) has a predicted length of 400 amino acids and MW of 44 kDa. A concentration of 0.5 µg/mL is recommended for IHC to detect the protein in formalin fixed and paraffin embedded tissues. Heat mediated antigen retrieval is required. Biosensis recommends optimal dilutions/concentrations should be determined by the end user.
TargetCytoskeletal 19
SpecificityThe specificity of this antibody has been confirmed by WB and IHC against the antigen. Human
Target Host SpeciesHuman
Species ReactivityHuman
Antibody HostRabbit
Antibody TypePolyclonal
Antibody IsotypeIgG
ConjugateUnconjugated
Immunogen DescriptionA synthetic peptide corresponding to a region (379-392 aa) from the C-terminus of human Cytoskeletal 19.
Reconstitution InstructionsSpin vial briefly before opening. Reconstitute in 100 µL sterile-filtered, ultrapure water to achieve an antibody concentration of 1 mg/mL. Centrifuge to remove any insoluble material.
Storage InstructionsAt least 12 months after purchase at 2-8°C (lyophilized formulations). After reconstitution, aliquot and store at -20°C for a higher stability. Avoid freeze-thaw cycles.
Batch NumberPlease see item label.
Expiration Date12 months after date of receipt (unopened vial).
Alternative NamesKeratin; type I cytoskeletal 19; Cytokeratin-19; CK-19; Keratin-19; K19; KRT19; CK19;
Scientific BackgroundCytoskeletal 19 (CK-19) belongs to the intermediate filament family and is involved in the organization of myofibres (Ref: SWISSPROT).